Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKCOM Regulatory News (KCOM)

  • There is currently no data for KCOM

Directorate Change

17 May 2018 12:00

RNS Number : 4438O
KCOM Group PLC
17 May 2018
 

17 May 2018

 

KCOM Group PLC

Directorate change

 

KCOM Group PLC (KCOM.L) ("Company") announces today that Jane Aikman, Chief Financial Officer and Executive Director, has decided to leave the business to pursue other opportunities. Jane will remain with the Group to ensure that an orderly handover of her responsibilities takes place, including the finalisation of the year-end audit, and will continue as a Director until 30 June 2018.

 

The search process will begin immediately to find her successor.

 

Graham Holden, Chairman said:

 

"Jane has made an important contribution to the business, particularly her input into the further development and refinement of the Group strategy and clearer business segmentation. She has built strong, commercially focused teams and delivered improved overall governance and controls.

 

"I would like to thank her for her dedication and commitment to KCOM and for her support in the orderly transition of her responsibilities. On behalf of the Board, I would like to wish her all the best for the future."

 

KCOM Group will be announcing its full year results for the year ending 31 March 2018 on 5 June 2018. 

 

The Company stated in its trading update ahead of its Capital Markets Day on 1 February 2018 that the Group remains on track to deliver an overall EBITDA performance that is slightly ahead of the Board's expectation, and a revenue performance slightly behind, for the financial year ended 31 March 2018. 

 

An update on the process regarding the managed succession for Bill Halbert, the Group's Chief Executive will be provided at the full year results.

 

 

Enquiries:

FTI Consulting LLP

020 3727 1137

Edward Bridges/Matt Dixon/Jamie Ricketts/Leah Dudley

KCOM Group PLC

01482 602 595

Cathy Phillips, Investor Relations

 

 

The payments to be made to Jane after she leaves the business are set out below. There will be no other compensation paid for loss of office. Full details of the relevant payments will be included in the Directors' Remuneration Report for the relevant year. All payments are made in accordance with the Directors' Remuneration Policy which was approved by shareholders on 21 July 2017.

 

Salary and Benefits 

 

Jane will receive a lump sum payment in lieu of her notice period of 12 months in accordance with her contractual entitlement calculated as the sum of her base salary of £290,000, and the value of benefits of £18,456 and retirement benefits of £58,000. Her benefits consist of a car allowance, private medical insurance, health screening, income protection and life assurance.

 

The Company has also agreed to make a contribution to Jane's legal fees incurred in connection with her departure, in accordance with the Directors' Remuneration Policy.

 

Annual Bonus

 

The Remuneration Committee has agreed that Jane will also receive any bonus for which she is eligible under the annual bonus scheme for the year ended 31 March 2018, for which the calculations are still subject to external audit, due to her contribution to the business throughout the financial year. Further information on details of the bonus scheme, and the amount payable, will be included in the Directors' Remuneration Report.

 

Long Term Incentives

 

Jane was granted awards under the KCOM LTIP in January 2017 and July 2017. The performance periods for these awards end in January 2020 and July 2020 respectively. As a good leaver, Jane will be entitled to receive any shares that vest under the LTIP, pro-rated to 30 June 2019, in line with her 12 month notice period. The actual amount of shares will therefore be calculated on each vesting date, in so far as performance conditions are met at that time. Full details will be disclosed in the Directors' Remuneration Report in 2020 and 2021. Further details of the operation of the LTIP can be found in the Directors' Remuneration Report which will be published shortly in the Report & Accounts.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFKODNKBKDDPD
Date   Source Headline
31st Jan 20147:00 amRNSInterim Management Statement
13th Jan 20144:56 pmRNSDirector/PDMR Shareholding
20th Dec 20133:00 pmRNSHolding(s) in Company
12th Dec 20134:22 pmRNSDirector/PDMR Shareholding
26th Nov 20137:02 amRNSDirectorate Change
26th Nov 20137:00 amRNSHalf Yearly Report
13th Nov 20139:32 amRNSDirector/PDMR Shareholding
31st Oct 20134:25 pmRNSEmployee Benefit Trust Dealing
14th Oct 20134:59 pmRNSHolding(s) in Company
14th Oct 201311:21 amRNSDirector/PDMR Shareholding
30th Sep 20134:02 pmRNSDirector/PDMR Shareholding
30th Sep 20137:00 amRNSTrading Statement
11th Sep 20134:44 pmRNSDirector/PDMR Shareholding
12th Aug 20135:21 pmRNSDirector/PDMR Shareholding
6th Aug 201310:21 amRNSDirector/PDMR Shareholding
6th Aug 201310:06 amRNSDirector/PDMR Shareholding
5th Aug 201311:56 amRNSDirector/PDMR Shareholding
1st Aug 20137:00 amRNSBlocklisting Interim Review
26th Jul 20134:49 pmRNSResult of AGM
26th Jul 20137:00 amRNSInterim Management Statement
25th Jul 20137:00 amRNSDirector/PDMR Shareholding
19th Jul 20139:16 amRNSDoc re. Employee Benefit Trust Dealing
17th Jul 20135:41 pmRNSDirector/PDMR Shareholding
15th Jul 20137:00 amRNSDirector/PDMR Shareholding
28th Jun 20135:12 pmRNSDirector/PDMR Shareholding
13th Jun 201311:12 amRNSDirector/PDMR Shareholding
7th Jun 20137:00 amRNSFinal Results
14th May 201310:49 amRNSDirector/PDMR Shareholding
7th May 20134:27 pmRNSNotice of Results
3rd May 20134:00 pmRNSAppointment of Joint Broker
15th Apr 20132:27 pmRNSDirector/PDMR Shareholding
4th Apr 20137:00 amRNSPre-close Announcement and Pension Update
15th Mar 20134:37 pmRNSPrice Monitoring Extension
12th Mar 201312:25 pmRNSDirector/PDMR Shareholding
22nd Feb 20131:55 pmRNSHolding(s) in Company
18th Feb 201310:04 amRNSHolding(s) in Company
13th Feb 201311:34 amRNSDirector/PDMR Shareholding
7th Feb 20137:00 amRNSBlocklisting Interim Review
7th Feb 20137:00 amRNSDirector/PDMR Shareholding
6th Feb 201311:30 amRNSAppointment of Joint Brokers
1st Feb 20137:00 amRNSInterim Management Statement
29th Jan 20133:42 pmRNSDirector/PDMR Shareholding
15th Jan 201310:00 amRNSDirector/PDMR Shareholding
18th Dec 201211:35 amRNSDirector/PDMR Shareholding
12th Dec 20122:58 pmRNSDirector/PDMR Shareholding
10th Dec 20125:13 pmRNSHolding(s) in Company
4th Dec 20122:32 pmRNSDirector/PDMR Shareholding
28th Nov 20121:57 pmRNSDirector/PDMR Shareholding
27th Nov 20123:16 pmRNSDirector/PDMR Shareholding
27th Nov 20127:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.